These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 1770657)

  • 21. [A case of meningioma with non-accumulation of 99mTc-ECD and increased accumulation of 99mTc-HMPAO in the tumor].
    Kashimada A; Machida K; Honda N; Mamiya T; Takahashi T; Kamano T; Muramatsu M; Inoue Y
    Kaku Igaku; 1992 Sep; 29(9):1127-31. PubMed ID: 1453563
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Technetium-99m-labeled liposomes to image experimental colitis in rabbits: comparison with technetium-99m-HMPAO-granulocytes and technetium-99m-HYNIC-IgG.
    Dams ET; Oyen WJ; Boerman OC; Storm G; Laverman P; Koenders EB; van der Meer JW; Corstens FH
    J Nucl Med; 1998 Dec; 39(12):2172-8. PubMed ID: 9867164
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early and delayed imaging of Tc-99m HMPAO versus Tl-201 in benign and malignant thyroid tumors. Similar uptake but different retention.
    Ohnishi T; Noguchi S; Murakami N; Harao M; Jinnouchi S; Hoshi H; Futami S; Nagamachi S; Watanabe K
    Clin Nucl Med; 1992 Oct; 17(10):806-11. PubMed ID: 1424358
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of technetium-99m-HMPAO and technetium-99m-ECD cerebral SPECT images in Alzheimer's disease.
    van Dyck CH; Lin CH; Smith EO; Wisniewski G; Cellar J; Robinson R; Narayan M; Bennett A; Delaney RC; Bronen RA; Hoffer PB
    J Nucl Med; 1996 Nov; 37(11):1749-55. PubMed ID: 8917168
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 99mTc-HMPAO-labeled autologous versus heterologous leukocytes for imaging infection.
    Gratz S; Rennen HJ; Boerman OC; Oyen WJ; Mast P; Behr TM; Corstens FH
    J Nucl Med; 2002 Jul; 43(7):918-24. PubMed ID: 12097463
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of technetium-99m-HMPAO and xenon-133 measurements of regional cerebral blood flow by SPECT.
    Payne JK; Trivedi MH; Devous MD
    J Nucl Med; 1996 Oct; 37(10):1735-40. PubMed ID: 8862321
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stabilization of [99mTc]HMPAO--1. Ethanolic preparation.
    Billinghurst MW; Abrams DN; Lawson MS
    Int J Rad Appl Instrum A; 1991; 42(7):607-12. PubMed ID: 1663094
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypofixation and hyperfixation of 99mTc-hexamethyl propyleneamine oxime in subacute cerebral infarction.
    Ogasawara K; Ogawa A; Koshu K; Konno H; Suzuki M; Yoshimoto T
    J Nucl Med; 2000 May; 41(5):795-9. PubMed ID: 10809194
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New synthesis route of active substance d,l-HMPAO for preparation Technetium Tc99m Exametazime.
    Pijarowska-Kruszyna J; Karczmarczyk U; Jaroń AW; Laszuk E; Radzik M; Garnuszek P; Mikołajczak R
    Nucl Med Rev Cent East Eur; 2017; 20(2):88-94. PubMed ID: 28555448
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intra-individual differences between technetium-99m-HMPAO and technetium-99m-ECD in the normal medial temporal lobe.
    Oku N; Matsumoto M; Hashikawa K; Moriwaki H; Ishida M; Seike Y; Terakawa H; Watanabe Y; Uehara T; Nishimura T
    J Nucl Med; 1997 Jul; 38(7):1109-11. PubMed ID: 9225799
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Difference in the distribution of 123I-IMP and 99mTc-HMPAO in the striatum--comparison with 15O-PET].
    Otsuka M; Ichiya Y; Kuwabara Y; Sasaki M; Akashi Y; Yoshida T; Fukumura T; Masuda K
    Kaku Igaku; 1993 Apr; 30(4):389-95. PubMed ID: 8315889
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A case of subacute stroke with high uptake of 99mTc-HMPAO in the reperfused infarct corresponding to low perfusion area].
    Sugawara Y; Tanada S; Murase K; Inoue T; Miki H; Okumura A; Hamamoto K; Ueda T; Ohta S; Sakaki S
    Kaku Igaku; 1994 Jun; 31(6):603-7. PubMed ID: 8072234
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Experimental and clinical evaluation of 99mTc-HMPAO as a sensitive marker for chemical lung injury].
    Suga K; Uchisako H; Nishigauchi K; Kume N; Tsukamoto K; Awaya H; Nakanishi T
    Kaku Igaku; 1994 Jun; 31(6):581-91. PubMed ID: 8072232
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The radiation dosimetry and normal value study of 99mTc-HMPAO-labeled leukocytes.
    Brown ML; Hung JC; Vetter RJ; O'Connor MK; Chowdhury S; Forstrom LA
    Invest Radiol; 1994 Apr; 29(4):443-7. PubMed ID: 8034450
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Technetium-99m-HMPAO cerebral perfusion scintigraphy: considerations for timely brain death declaration.
    Larar GN; Nagel JS
    J Nucl Med; 1992 Dec; 33(12):2209-11. PubMed ID: 1460517
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Leukocyte labeling with 99mTc-HMPAO. The role of the in vitro stability of HMPAO on the labeling efficacy and image quality.
    Papós M; Láng J; Rajtár M; Csernay L
    Nucl Med Biol; 1994 Aug; 21(6):893-5. PubMed ID: 9234340
    [No Abstract]   [Full Text] [Related]  

  • 37. Different uptake of 99mTc-ECD adn 99mTc-HMPAO in the same brains: analysis by statistical parametric mapping.
    Hyun Y; Lee JS; Rha JH; Lee IK; Ha CK; Lee DS
    Eur J Nucl Med; 2001 Feb; 28(2):191-7. PubMed ID: 11303889
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [99mTc HMPAO (technetium 99m-hexamethylpropyleneamine oxime) angioscintigraphy in the diagnosis of brain death].
    Abate A; Chini G; Amantini A; Ragazzoni A; Pieroni C
    Minerva Anestesiol; 1995; 61(7-8):329-34. PubMed ID: 8948745
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Non-invasive monitoring of photodynamic therapy with 99technetium HMPAO scintigraphy.
    Moore RB; Chapman JD; Mokrzanowski AD; Arnfield MR; McPhee MS; McEwan AJ
    Br J Cancer; 1992 Apr; 65(4):491-7. PubMed ID: 1562457
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stabilisation of high-activity 99mTc-d,l-HMPAO preparations with cobalt chloride and their biological behaviour.
    Mang'era KO; Vanbilloen HP; Schiepers CW; Verbruggen AM
    Eur J Nucl Med; 1995 Oct; 22(10):1163-72. PubMed ID: 8542901
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.